High dose radionuclide complexes for bone marrow suppression

Details High dose radionuclide complexes for bone marrow suppression High dose radionuclide complexes for bone marrow suppression

2006-07-04

2006-07-04

Jones, Dameron L. (Department: 1618)

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

In an organic compound

C424S009100, C424S001110, C534S015000, C514S836000

Reexamination Certificate

active

07070759

ABSTRACT:
The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.

REFERENCES:
patent: 3032584 (1962-05-01), Bergel et al.
patent: 3032585 (1962-05-01), Bergel et al.
patent: 3398198 (1968-08-01), Kersnar et al.
patent: 3726912 (1973-04-01), McCrary et al.
patent: 3852414 (1974-12-01), Adler et al.
patent: 3931396 (1976-01-01), Bardy et al.
patent: 3965254 (1976-06-01), Tofe et al.
patent: 3974268 (1976-08-01), Subramanian et al.
patent: 3989730 (1976-11-01), Subramanian et al.
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4058704 (1977-11-01), Shimizu
patent: 4075314 (1978-02-01), Wolfangel et al.
patent: 4104366 (1978-08-01), Schmidt-Dunker et al.
patent: 4187284 (1980-02-01), Rolleston et al.
patent: 4399817 (1983-08-01), Benedict
patent: 4508625 (1985-04-01), Graham
patent: 4515767 (1985-05-01), Simon et al.
patent: 4560548 (1985-12-01), Simon et al.
patent: 4606907 (1986-08-01), Simon et al.
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4707353 (1987-11-01), Bugaj et al.
patent: 4752464 (1988-06-01), Lieberman et al.
patent: 4808541 (1989-02-01), Mikola et al.
patent: 4853209 (1989-08-01), Kaplan et al.
patent: 4882142 (1989-11-01), Simon et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4897254 (1990-01-01), Simon et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4898724 (1990-02-01), Simon et al.
patent: 4937333 (1990-06-01), Garlich et al.
patent: 4957939 (1990-09-01), Gries et al.
patent: 4976950 (1990-12-01), Simon et al.
patent: 5059412 (1991-10-01), Simon et al.
patent: 5064633 (1991-11-01), Simon et al.
patent: 5066478 (1991-11-01), Simon et al.
patent: 5089249 (1992-02-01), Fritzberg et al.
patent: 5202109 (1993-04-01), Fritzberg et al.
patent: 5286497 (1994-02-01), Hendrickson et al.
patent: 5300279 (1994-04-01), Simon et al.
patent: 5393512 (1995-02-01), Vanderheyden et al.
patent: 5587451 (1996-12-01), Athey et al.
patent: 5621001 (1997-04-01), Canetta et al.
patent: 5641803 (1997-06-01), Canetta et al.
patent: 5665761 (1997-09-01), Canetta et al.
patent: 5670537 (1997-09-01), Canetta et al.
patent: 5679318 (1997-10-01), Vanderheyden et al.
patent: 5707610 (1998-01-01), Ibsen et al.
patent: 5708169 (1998-01-01), Hester, Jr. et al.
patent: 5712275 (1998-01-01), Van Gestel
patent: 5714467 (1998-02-01), Boman et al.
patent: 5714504 (1998-02-01), Lindberg et al.
patent: 5714604 (1998-02-01), Kiefer
patent: 5756472 (1998-05-01), Liesch et al.
patent: 5756505 (1998-05-01), Nishino et al.
patent: 5756685 (1998-05-01), Fritzberg et al.
patent: 5756725 (1998-05-01), Wilkening et al.
patent: 5760063 (1998-06-01), Lam et al.
patent: 5762907 (1998-06-01), Simon et al.
patent: 5770617 (1998-06-01), LaVoie et al.
patent: 5773421 (1998-06-01), Alder et al.
patent: 5773443 (1998-06-01), Ray et al.
patent: 5773696 (1998-06-01), Liang et al.
patent: 5783570 (1998-07-01), Yokota et al.
patent: 5786325 (1998-07-01), Borromeo et al.
patent: 5801172 (1998-09-01), Clapp-Shapiro et al.
patent: 5807854 (1998-09-01), Bartroli et al.
patent: 5814634 (1998-09-01), Nishino et al.
patent: 5824698 (1998-10-01), Hasler et al.
patent: 5824874 (1998-10-01), Ulbrich et al.
patent: 5830855 (1998-11-01), Takemoto
patent: 5830889 (1998-11-01), Iwata et al.
patent: 5837253 (1998-11-01), Cohen
patent: 5837726 (1998-11-01), Liu et al.
patent: 5849956 (1998-12-01), Koga et al.
patent: 5854213 (1998-12-01), Bouffard
patent: 5854280 (1998-12-01), Gomez et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 5859032 (1999-01-01), Nishino et al.
patent: 5861430 (1999-01-01), Markonius
patent: 5863773 (1999-01-01), Gunawardana et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 5872249 (1999-02-01), Park et al.
patent: 5876738 (1999-03-01), Ohno et al.
patent: 5888526 (1999-03-01), Tsubai et al.
patent: 5888941 (1999-03-01), Bartroli et al.
patent: 5891890 (1999-04-01), Nishino et al.
patent: 5908862 (1999-06-01), Wai Lee et al.
patent: 5910498 (1999-06-01), Yazaki et al.
patent: 5917084 (1999-06-01), Jiang
patent: 5919438 (1999-07-01), Saint-Leger
patent: 5919925 (1999-07-01), Burton et al.
patent: 6005083 (1999-12-01), Kasina
patent: 6177551 (2001-01-01), Kasina
patent: 6187910 (2001-02-01), Kasina
patent: 6241961 (2001-06-01), Benes et al.
patent: 6528627 (2003-03-01), Kasina
patent: 6767531 (2004-07-01), Fritzberg et al.
patent: 2002/0176818 (2002-11-01), Fritzberg et al.
patent: 2003/0118508 (2003-06-01), Simon et al.
patent: 2003/0158393 (2003-08-01), Kasina
patent: 2004/0096393 (2004-05-01), Fritzberg
patent: 2004/0126317 (2004-07-01), Fritzberg
patent: 2005/0063905 (2005-03-01), Fritzberg et al.
patent: 1078731 (1980-06-01), None
patent: 0 164 843 (1985-12-01), None
patent: 0 210 043 (1987-01-01), None
patent: 0 232 751 (1987-08-01), None
patent: 0 255 471 (1988-02-01), None
patent: 0 258 616 (1988-03-01), None
patent: 0 287 465 (1988-10-01), None
patent: 0 374 501 (1990-06-01), None
patent: 0 382 582 (1990-08-01), None
patent: 0 408 701 (1991-01-01), None
patent: 0 411 941 (1991-02-01), None
patent: 0 455 380 (1991-11-01), None
patent: 0 698 029 (1996-02-01), None
patent: 0 972 528 (2000-01-01), None
patent: 2230374 (1974-12-01), None
patent: WO 84/03698 (1984-09-01), None
patent: WO 90/06776 (1990-06-01), None
patent: WO 91/16075 (1991-10-01), None
patent: WO 93/25240 (1993-12-01), None
patent: WO 01/91806 (2001-12-01), None
patent: WO 02/062398 (2002-08-01), None
“Abstract Book, Annual Congress of the EANM”,European Journal of Nuclear Medicine and Molecular Imaging, 31, Helsinki, 2004, including abstracts p. 908, p. 925-p. 936, and p. 946-p. 952 (2004).
“Manufacture of Triethylene Tetramine”,Research Disclosure, 315, No. 31591, 595 (1990).
Goldman, “Good Drug, Bad Luck: Business, Regulatory Issues Can Create Obstacles for Drug Development”,Journal of the National Cancer Institute, 96, 1573-1574 (2004).
Kyle et al., “Multiple Myeloma”,The New England Journal of Medicine, 351, 1860-1873 (2004).
“Bone Cancer Therapy Project Funding Awarded to Brookhaven National Laboratory for Diatide-Licensed Product”, DISTRIBUTION: Business Editors and Health/Medical Writers (1999).
“Breast Cancer; Genitourinary Cancer; Multiple Myeloma”,Annotated Guide to Cancer Chemotherapeutic Regimens 1999/2000, Oncology Special Edition, 13-14; 17-18; 32.
“Chapter III: Chemotherapy Regimens in Adults”,In Cancer Chemotherapy Pocket Guide, Robert J. Ignoffo, Editor, 248-255; 338-341 (1998).
“Multiple Myeloma”,In Clinical Oncology, A Multidisciplinary Approach for Physicians and Students, 7th Edition, Philip Rubin, Editor, 239-244 (1993).
“NeoRx Updates Skeletal Targeted Radiotherapy (STR) Phase I/II Trail Data”,NeoRx Press Release(2001).
“NeoRx's Multiple Myeloma Study with Targeted Radiotherapy to be Updated at ASH—Recent Thalidomide Results Heighten Interest in New Multiple Myeloma Therapies”,NeoRx Press Release(1999).
“NeoRx's Targeted Radiotherapy Achieves Complete Responses with Excellent Safety in Multiple Myeloma Patients”,NeoRx Press Release(1999).
“Phase I/II Interim Data on NeoRx's STR Product in Multiple Myeloma”,NeoRx Press Release(1999).
Abrams, “High-Dose Targeted Radiation to Bone and Bone Metastases”,CaP CURE Meeting, Lake Tahoe, NV, 2 pages (2000).
Alexanian et al., “Impact of Complete Remission with Intensive Therapy in Patients with Responsive Multiple Myeloma”,British Journal of Hematology, 27(10), 1037-1043 (2001).
Anderson et al., “High-Dose Samarium-153 Ethylene Diamine Tetramethylene Phosphonate: Low Toxicity of Skeletal Irradiation in Patients with Osteo

Affiliated with

Also associated with

Rating

High dose radionuclide complexes for bone marrow suppression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with High dose radionuclide complexes for bone marrow suppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High dose radionuclide complexes for bone marrow suppression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3533842